Literature DB >> 16311605

A role for LEDGF/p75 in targeting HIV DNA integration.

Angela Ciuffi1, Manuel Llano, Eric Poeschla, Christian Hoffmann, Jeremy Leipzig, Paul Shinn, Joseph R Ecker, Frederic Bushman.   

Abstract

HIV DNA integration is favored in active genes, but the underlying mechanism is unclear. Cellular lens epithelium-derived growth factor (LEDGF/p75) binds both chromosomal DNA and HIV integrase, and might therefore direct integration by a tethering interaction. We analyzed HIV integration in cells depleted for LEDGF/p75, and found that integration was (i) less frequent in transcription units, (ii) less frequent in genes regulated by LEDGF/p75 and (iii) more frequent in GC-rich DNA. LEDGF is thus the first example of a cellular protein controlling the location of HIV integration in human cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16311605     DOI: 10.1038/nm1329

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  330 in total

1.  LEDGF (p75) promotes DNA-end resection and homologous recombination.

Authors:  Mads Daugaard; Annika Baude; Kasper Fugger; Lou Klitgaard Povlsen; Halfdan Beck; Claus Storgaard Sørensen; Nikolaj H T Petersen; Poul H B Sorensen; Claudia Lukas; Jiri Bartek; Jiri Lukas; Mikkel Rohde; Marja Jäättelä
Journal:  Nat Struct Mol Biol       Date:  2012-07-08       Impact factor: 15.369

Review 2.  HIV DNA integration.

Authors:  Robert Craigie; Frederic D Bushman
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

3.  Mechanisms and inhibition of HIV integration.

Authors:  Christophe Marchand; Allison A Johnson; Elena Semenova; Yves Pommier
Journal:  Drug Discov Today Dis Mech       Date:  2006-07-01

4.  Rational design of small-molecule inhibitors of the LEDGF/p75-integrase interaction and HIV replication.

Authors:  Frauke Christ; Arnout Voet; Arnaud Marchand; Stefan Nicolet; Belete A Desimmie; Damien Marchand; Dorothée Bardiot; Nam Joo Van der Veken; Barbara Van Remoortel; Sergei V Strelkov; Marc De Maeyer; Patrick Chaltin; Zeger Debyser
Journal:  Nat Chem Biol       Date:  2010-05-16       Impact factor: 15.040

5.  Determinants that specify the integration pattern of retrotransposon Tf1 in the fbp1 promoter of Schizosaccharomyces pombe.

Authors:  Anasuya Majumdar; Atreyi Ghatak Chatterjee; Tracy L Ripmaster; Henry L Levin
Journal:  J Virol       Date:  2010-10-27       Impact factor: 5.103

6.  Contribution of host nucleoporin 62 in HIV-1 integrase chromatin association and viral DNA integration.

Authors:  Zhujun Ao; Kallesh Danappa Jayappa; Binchen Wang; Yingfeng Zheng; Xiaoxia Wang; Jinyu Peng; Xiaojian Yao
Journal:  J Biol Chem       Date:  2012-02-03       Impact factor: 5.157

7.  Methods for the Analyses of Inhibitor-Induced Aberrant Multimerization of HIV-1 Integrase.

Authors:  Jacques J Kessl; Amit Sharma; Mamuka Kvaratskhelia
Journal:  Methods Mol Biol       Date:  2016

8.  Differential effects of human immunodeficiency virus type 1 capsid and cellular factors nucleoporin 153 and LEDGF/p75 on the efficiency and specificity of viral DNA integration.

Authors:  Yasuhiro Koh; Xiaolin Wu; Andrea L Ferris; Kenneth A Matreyek; Steven J Smith; KyeongEun Lee; Vineet N KewalRamani; Stephen H Hughes; Alan Engelman
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

9.  A resurrected mammalian hAT transposable element and a closely related insect element are highly active in human cell culture.

Authors:  Xianghong Li; Hosam Ewis; Robert H Hice; Nirav Malani; Nicole Parker; Liqin Zhou; Cédric Feschotte; Frederic D Bushman; Peter W Atkinson; Nancy L Craig
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-22       Impact factor: 11.205

10.  Bromo- and extraterminal domain chromatin regulators serve as cofactors for murine leukemia virus integration.

Authors:  Saumya Shree Gupta; Tobias Maetzig; Goedele N Maertens; Azar Sharif; Michael Rothe; Magdalena Weidner-Glunde; Melanie Galla; Axel Schambach; Peter Cherepanov; Thomas F Schulz
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.